PMID- 31932544
OWN - NLM
STAT- MEDLINE
DCOM- 20200622
LR  - 20200622
IS  - 1347-3409 (Electronic)
IS  - 1345-4676 (Linking)
VI  - 86
IP  - 6
DP  - 2019
TI  - Nomograms to Predict Survival in Patients with Lung Squamous Cell Cancer: A 
      Population-Based Study.
PG  - 336-344
LID - 10.1272/jnms.JNMS.2020_86-610 [doi]
AB  - BACKGROUND: This study aimed to identify risk factors affecting cancer-specific 
      survival (CSS) and overall survival (OS) in patients with lung squamous cell 
      carcinoma (LSCC) and to develop nomograms for prognostic prediction in these 
      patients. METHODS: Patients who received an LSCC diagnosis between 2007 and 2013 
      were selected from the Surveillance, Epidemiology, and End Results (SEER) 
      database. The prognostic effect of each variable on survival was evaluated with 
      Cox regression and Kaplan-Meier analysis, and nomograms were developed to predict 
      3-, 5-, and 7-year CSS and OS rates. RESULTS: Data from 23,004 patients with LSCC 
      were analyzed. Nomograms were first developed by using variables that were 
      significantly associated with CSS and OS and then validated by using an internal 
      bootstrap resampling approach, which showed that they had a sufficient level of 
      discrimination, according to the C-index. CONCLUSIONS: The nomograms 
      satisfactorily predicted 3-, 5-, and 7-year CSS and OS rates for patients with 
      LSCC.
FAU - Zheng, Rongjiong
AU  - Zheng R
AD  - Department of Pulmonology, Ningbo Yinzhou Second Hospital.
FAU - Gu, Xiaolong
AU  - Gu X
AD  - Department of Pulmonology, Ningbo Yinzhou Second Hospital.
FAU - Wang, Mingming
AU  - Wang M
AD  - Department of Pulmonology, Ningbo Yinzhou Second Hospital.
FAU - Hu, Meiling
AU  - Hu M
AD  - Cixi People's Hospital of Zhejiang Province.
FAU - Xu, Haiqi
AU  - Xu H
AD  - Department of Pulmonology, Ningbo Yinzhou Second Hospital.
LA  - eng
PT  - Journal Article
PL  - Japan
TA  - J Nippon Med Sch
JT  - Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
JID - 100935589
SB  - IM
MH  - Carcinoma, Squamous Cell/*pathology/therapy
MH  - Female
MH  - Humans
MH  - Kaplan-Meier Estimate
MH  - Lung Neoplasms/*pathology/therapy
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - Nomograms
MH  - Population Surveillance/*methods
MH  - Prognosis
MH  - Risk Assessment/methods/statistics & numerical data
MH  - Risk Factors
MH  - Socioeconomic Factors
OTO - NOTNLM
OT  - lung squamous cell carcinoma
OT  - nomogram
OT  - risk factors
EDAT- 2020/01/15 06:00
MHDA- 2020/06/23 06:00
CRDT- 2020/01/15 06:00
PHST- 2020/01/15 06:00 [entrez]
PHST- 2020/01/15 06:00 [pubmed]
PHST- 2020/06/23 06:00 [medline]
AID - 10.1272/jnms.JNMS.2020_86-610 [doi]
PST - ppublish
SO  - J Nippon Med Sch. 2019;86(6):336-344. doi: 10.1272/jnms.JNMS.2020_86-610.